Sfoglia per AUTORE
BUNGARO M
Collezione ASL Torino 4

  

Items : 5

Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2023 Aug;189:112920. doi: 10.1016/j.ejca.2023.05.008. Epub 2023 May 15.

2023
AO Cuneo
ASL Cuneo 2
AO Ordine Mauriziano
ASL Torino 4
AOU San Luigi di Orbassano

Di Maio M; Tuninetti V; Turco F; Fabi A; Perrone F; Paratore C; Reale ML; Trastu F; Mariniello A; Marandino L; Lombardi P; Caglio A; Di Liello R; Rossi A; Ghisoni E; Gargiulo P; Gamba T; Audisio M; Aimar G; Bungaro M;

COVID-19 and Lung Cancer: A Comprehensive Overview from Outbreak to Recovery. in Biomedicines / Biomedicines. 2022 Mar 26;10(4):776. doi: 10.3390/biomedicines10040776.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Scagliotti GV; Passiglia F; Bungaro M;

Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective study. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Dec;74(6):703-713. doi: 10.23736/S2724-6051.22.04701-2. Epub 2022 Feb 11.

2022
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Scagliotti GV; Buttigliero C; Tucci M; DI Maio M; Pisano C; Parente A; Bungaro M; Samuelly A; Turco F; Angusti T; DI Stefano RF;

A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Apr;172:103639. doi: 10.1016/j.critrevonc.2022.103639. Epub 2022 Feb 19

2022
ASL Asti
AOU Città della Salute di Torino
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Capelletto E; Scagliotti GV; Novello S; Buffoni L; Passiglia F; Carnio S; Zichi C; Reale ML; Artusio E; Rapetti SG; Audisio M; Bertaglia V; Tagliamento M; Paratore C; Bungaro M; Olmetto E; Curcio H; De Luca E; Pignataro D; Bironzo P;

Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide. in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):803-814. doi: 10.23736/S2724-6051.21.04186-2. Epub 2021 Mar 29.

2021
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
ASL Torino 4
AO Ordine Mauriziano

Buttigliero C; DI Maio M; Scagliotti GV; Tarenghi F; Vignani F; Bungaro M; Samuelly A; Turco F; DI Stefano RF; Tucci M; Pisano C;